OMALIZUMAB

Indications and dose

Prophylaxis of severe persistent allergic asthma

By subcutaneous injection

  • Child 6–17 years

    Dose according to immunoglobulin E concentration and body-weight (consult produc...

This item requires a subscription.
For full access to this content, log in to an existing user account or purchase an individual subscription.
×
Sign in or create an account
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. Sign in or purchase a subscription to access this content. ×